| Deriving a pan-omics diagnostic pipeline for systems level immune health and therapeutic targeting in systemic autoimmunity | Life Sciences & Biotechnology, Medical Sciences | 2020 | 2025 |
| Leishmaniasis: target specific approaches to affect host-pathogen interaction and disease process | Life Sciences & Biotechnology, Medical Sciences | 2020 | 2025 |
| Modern innovative solutions for environmental/ occupational lung health challenges using clinical and pre -clinical strategies | Earth, Atmosphere & Environment Sciences, Life Sciences & Biotechnology, Medical Sciences | 2020 | 2025 |
| Non-alcoholic fatty liver disease (NAFLD): Novel pathogenic mechanism and therapeutic development | Life Sciences & Biotechnology, Medical Sciences | 2020 | 2025 |
| Targeting RNA driven processes: Novel chemical biology approaches to identify new classes of RNA modulators | Life Sciences & Biotechnology | 2020 | 2025 |
| Molecular basis of evolutionary divergence in RNAi initiation | Life Sciences & Biotechnology, Medical Sciences | 2020 | 2023 |
| Quality control of regulatory complex biogenesis | Life Sciences & Biotechnology | 2020 | 2023 |
| Investigating interactions at the host-pathogen interface in the pathogenesis of Mycobacterium tuberculosis | Life Sciences & Biotechnology, Medical Sciences | 2020 | 2023 |
| Mechanistic insights into bacterial growth and morphogenesis | Life Sciences & Biotechnology, Medical Sciences | 2020 | 2023 |
| Membrane lipids and the actin cytoskeleton in GPCR endocytosis: Implications in health and disease | Life Sciences & Biotechnology | 2020 | 2023 |